Chi ST Vincent Hospital Hot Springs
Chi ST Vincent Hospital Hot Springs was paid $236K by Medicaid between Jul 2020 and Mar 2022, across 157 billing codes. Its largest line is 96365, Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour — 9.1% of everything it billed.
HOT SPRINGS, AR 71913
Next to other Psychiatric Hospital Unit providers in Arkansas
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 86 | $83.70 | |
| 2021 | 22,318 | $199K | |
| 2022 | 13,609 | $36K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 9.1% | 310 | 256 | $21K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 8.6% | 730 | 578 | $20K |
| 59025 | Fetal non-stress test | 5.8% | 370 | 167 | $14K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.6% | 269 | 251 | $13K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.4% | 1,285 | 1,148 | $10K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.2% | 260 | 248 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.5% | 2,546 | 2,150 | $8K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.4% | 1,650 | 1,373 | $8K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 3.3% | 241 | 132 | $8K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.2% | 772 | 246 | $8K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.7% | 888 | 848 | $6K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.5% | 140 | 135 | $6K |
145 more codes
| 72125 | Computed tomography, cervical spine; without contrast material | 2.5% | 110 | $6K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.2% | 234 | $5K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.2% | 234 | $5K |
| 36415 | Collection of venous blood by venipuncture | 2.0% | 1,245 | $5K |
| 80081 | 1.9% | 96 | $4K | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | 1.8% | 1,713 | $4K |
| 80053 | Comprehensive metabolic panel | 1.7% | 768 | $4K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 1.7% | 32 | $4K |
| 97161 | 1.4% | 130 | $3K | |
| 71045 | Radiologic examination, chest; single view | 1.1% | 726 | $3K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1.1% | 46 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 754 | $3K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1.1% | 45 | $2K |
| 99285 | Emergency room visit (most serious) | <1% | 328 | $2K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 49 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 228 | $2K |
| 84484 | <1% | 431 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 801 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 649 | $2K |
| 87653 | <1% | 106 | $2K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 169 | $1K |
| 82077 | <1% | 211 | $1K | |
| 83880 | <1% | 123 | $1K | |
| 87088 | <1% | 364 | $1K | |
| 71250 | <1% | 34 | $1K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 91 | $1K |
| 86901 | <1% | 136 | $1K | |
| 82947 | <1% | 425 | $1K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 42 | $965.87 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 994 | $925.64 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 128 | $923.51 |
| 81025 | <1% | 442 | $906.72 | |
| 90715 | <1% | 74 | $879.56 | |
| 94726 | <1% | 58 | $858.03 | |
| 80047 | <1% | 69 | $770.54 | |
| 80143 | <1% | 95 | $770.16 | |
| 80179 | <1% | 94 | $727.85 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 59 | $713.61 |
| 90686 | <1% | 44 | $711.90 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 98 | $646.42 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 661 | $645.48 |
| 83690 | <1% | 331 | $645.46 | |
| 82677 | <1% | 58 | $633.83 | |
| 86850 | <1% | 146 | $625.46 | |
| 94729 | <1% | 57 | $610.42 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 36 | $581.00 |
| 12002 | <1% | 12 | $567.50 | |
| G0008 | Administration of influenza virus vaccine | <1% | 44 | $564.54 |
| 80061 | Lipid panel | <1% | 125 | $549.12 |
| 86900 | <1% | 132 | $544.47 | |
| 81003 | <1% | 655 | $521.14 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 82 | $499.93 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 121 | $477.65 |
| 82105 | <1% | 74 | $463.45 | |
| 80076 | <1% | 130 | $439.41 | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 31 | $429.61 |
| 82803 | <1% | 70 | $409.20 | |
| 86336 | <1% | 58 | $399.49 | |
| 81001 | <1% | 427 | $394.20 | |
| 84702 | <1% | 151 | $385.82 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 183 | $371.82 |
| 80074 | <1% | 27 | $354.93 | |
| 85610 | <1% | 197 | $315.89 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 297 | $308.63 |
| 93017 | <1% | 51 | $303.32 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 46 | $300.27 |
| 83605 | <1% | 91 | $286.86 | |
| 86592 | <1% | 179 | $286.17 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 88 | $266.37 |
| 94760 | <1% | 29 | $259.22 | |
| 85730 | <1% | 65 | $257.02 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 520 | $246.26 |
| 74018 | <1% | 52 | $239.27 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 34 | $231.54 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 867 | $230.95 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 90 | $229.76 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 837 | $227.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 64 | $223.01 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 352 | $222.04 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 27 | $219.27 |
| 87077 | <1% | 198 | $215.54 | |
| 94761 | <1% | 71 | $203.56 | |
| 97016 | <1% | 32 | $172.90 | |
| 87186 | <1% | 203 | $165.21 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 96 | $149.30 |
| A9270 | Non-covered item or service | <1% | 253 | $143.46 |
| 73030 | <1% | 18 | $142.57 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 46 | $141.32 |
| 87070 | <1% | 93 | $138.62 | |
| 87081 | <1% | 111 | $135.14 | |
| 87040 | <1% | 15 | $132.75 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 128 | $131.66 |
| 36600 | <1% | 13 | $126.09 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 39 | $122.99 |
| 87210 | <1% | 74 | $113.10 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 309 | $113.00 |
| 85379 | <1% | 42 | $105.63 | |
| 84439 | <1% | 30 | $100.60 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 298 | $98.32 |
| J2704 | Injection, propofol, 10 mg | <1% | 308 | $94.84 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 21 | $89.89 |
| 76642 | <1% | 12 | $74.36 | |
| 87147 | <1% | 32 | $73.90 | |
| 83735 | <1% | 85 | $72.15 | |
| 97014 | <1% | 26 | $69.24 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 104 | $67.62 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 175 | $62.88 |
| 85027 | <1% | 69 | $60.50 | |
| J1815 | Injection, insulin, per 5 units | <1% | 41 | $58.33 |
| 84703 | <1% | 47 | $53.65 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,291 | $51.31 |
| 72170 | <1% | 15 | $47.67 | |
| 80164 | <1% | 12 | $43.90 | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 43 | $43.01 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 31 | $35.88 |
| 87205 | <1% | 34 | $30.50 | |
| S0028 | Injection, famotidine, 20 mg | <1% | 263 | $27.71 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 64 | $27.13 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 76 | $25.70 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 181 | $23.52 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 26 | $22.35 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 16 | $17.70 |
| 86140 | <1% | 54 | $16.78 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 32 | $10.88 |
| 83721 | 0% | 33 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 197 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 100 | $0.00 |
| 71046 | Radiologic examination, chest; 2 views | 0% | 13 | $0.00 |
| 72131 | 0% | 14 | $0.00 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 0% | 15 | $0.00 |
| 84156 | 0% | 23 | $0.00 | |
| 97116 | 0% | 33 | $0.00 | |
| 36416 | 0% | 54 | $0.00 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 0% | 129 | $0.00 |
| 96376 | 0% | 96 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 35 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 468 | $0.00 |
| 74420 | 0% | 32 | $0.00 | |
| 93458 | 0% | 13 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 92 | $0.00 |
| 94762 | 0% | 40 | $0.00 | |
| 99406 | 0% | 16 | $0.00 | |
| 73560 | 0% | 15 | $0.00 | |
| 93971 | 0% | 17 | $0.00 | |
| C1769 | Guide wire | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Chi ST Vincent Hospital Hot Springs | Hot Springs, AR | $16.38M |
| ST Vincent Infirmary Medical Center | Little Rock, AR | $8.31M |
| ST. Vincent Infirmary Medical Center | Sherwood, AR | $2.98M |
| ST. Vincent Infirmary Medical Center | Little Rock, AR | $121K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.